Aurora Cannabis vs Canopy Growth
ACB and CGC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACB and CGC compare
Aurora Cannabis grew revenue faster over the last twelve months (11.0% versus 10.7% for Canopy Growth).
Aurora Cannabis scores higher on the StockData Score (6 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACB | CGC |
|---|---|---|
| Size and price | ||
| Share price | $4.94 | $0.561 |
| Change, 1 year | 9.1% | −52.8% |
| Change, 5 years | −93.0% | −99.5% |
| Beta (5Y) | 1.31 | 1.89 |
| Employees | – | 1,128 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 11.0% (better) | 10.7% |
| Revenue growth, 5Y average | 5.5% (better) | −12.2% |
| EPS growth (TTM) | −5450% | – |
| Profitability | ||
| Gross margin | 42.6% (better) | 24.4% |
| Operating margin | – | −54.2% |
| Net margin | – | −87.0% |
| FCF margin | – | −25.8% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −3.7× |
| Current ratio | 5.94 (better) | 2.82 |
| Piotroski F-score | – | 5 |
| Ownership | ||
| Held by institutions | 8.9% | 6.9% |
| Held by insiders | 0.00% | 1.0% |
| Insider net buying, 12 months | – | −$393K |
Go deeper
- ACB stock overview
- ACB income statement
- ACB valuation and score
- CGC stock overview
- CGC income statement
- CGC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.